155 related articles for article (PubMed ID: 28444232)
1. Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus-Exposed, Uninfected Infants in Malawi: The BAN Study.
Davis NL; Wiener J; Juliano JJ; Adair L; Chasela CS; Kayira D; Hudgens MG; van der Horst C; Jamieson DJ; Kourtis AP; ;
Clin Infect Dis; 2017 Aug; 65(4):575-580. PubMed ID: 28444232
[TBL] [Abstract][Full Text] [Related]
2. Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.
Davis NL; Barnett EJ; Miller WC; Dow A; Chasela CS; Hudgens MG; Kayira D; Tegha G; Ellington SR; Kourtis AP; van der Horst C; Jamieson DJ; Juliano JJ
Clin Infect Dis; 2015 Aug; 61(3):368-74. PubMed ID: 25900173
[TBL] [Abstract][Full Text] [Related]
3. Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants.
Ewing AC; King CC; Wiener JB; Chasela CS; Hudgens MG; Kamwendo D; Tegha G; Hosseinipour MC; Jamieson DJ; Van der Horst C; Kourtis AP
AIDS; 2017 Nov; 31(18):2455-2463. PubMed ID: 28926409
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.
Sandison TG; Homsy J; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Kalamya J; Vora N; Kublin J; Kamya MR; Dorsey G; Tappero JW
BMJ; 2011 Mar; 342():d1617. PubMed ID: 21454456
[TBL] [Abstract][Full Text] [Related]
6. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.
Daniels B; Coutsoudis A; Moodley-Govender E; Mulol H; Spooner E; Kiepiela P; Reddy S; Zako L; Ho NT; Kuhn L; Ramjee G
Lancet Glob Health; 2019 Dec; 7(12):e1717-e1727. PubMed ID: 31708152
[TBL] [Abstract][Full Text] [Related]
7. Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants.
Dow A; Kayira D; Hudgens M; Van Rie A; King CC; Ellington S; Kourtis A; Turner AN; Meshnick S; Kacheche Z; Jamieson DJ; Chasela C; van der Horst C
Pediatr Infect Dis J; 2012 Aug; 31(8):842-7. PubMed ID: 22801093
[TBL] [Abstract][Full Text] [Related]
8. Initiation of anti-retroviral/Trimethoprim-Sulfamethoxazole therapy in a longitudinal cohort of HIV-1 positive individuals in Western Kenya rapidly decreases asymptomatic malarial parasitemia.
Kifude CM; Roberds A; Oyieko J; Ocholla S; Otieno S; Waitumbi JN; Hutter J; Smith H; Copeland NK; Luckhart S; Stewart VA
Front Cell Infect Microbiol; 2022; 12():1025944. PubMed ID: 36506016
[TBL] [Abstract][Full Text] [Related]
9. Co-trimoxazole prophylaxis for children who are HIV-exposed and uninfected: a systematic review.
Wedderburn CJ; Evans C; Slogrove AL; Rehman AM; Gibb DM; Prendergast AJ; Penazzato M
J Int AIDS Soc; 2023 Jun; 26(6):e26079. PubMed ID: 37292018
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
[TBL] [Abstract][Full Text] [Related]
11. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
Steketee RW; Wirima JJ; Slutsker L; Roberts JM; Khoromana CO; Heymann DL; Breman JG
Am J Trop Med Hyg; 1996; 55(1 Suppl):24-32. PubMed ID: 8702034
[TBL] [Abstract][Full Text] [Related]
12. The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected women.
Dow A; Kayira D; Hudgens MG; Van Rie A; King CC; Ellington S; Chome N; Kourtis A; Turner AN; Kacheche Z; Jamieson DJ; Chasela C; van der Horst C
Infect Dis Obstet Gynecol; 2013; 2013():340702. PubMed ID: 24363547
[TBL] [Abstract][Full Text] [Related]
13. Malaria and human immunodeficiency virus infection among male employees of a sugar estate in Malawi.
Nwanyanwu OC; Kumwenda N; Kazembe PN; Jemu S; Ziba C; Nkhoma WC; Redd SC
Trans R Soc Trop Med Hyg; 1997; 91(5):567-9. PubMed ID: 9463669
[TBL] [Abstract][Full Text] [Related]
14. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1.
Steketee RW; Wirima JJ; Bloland PB; Chilima B; Mermin JH; Chitsulo L; Breman JG
Am J Trop Med Hyg; 1996; 55(1 Suppl):42-9. PubMed ID: 8702036
[TBL] [Abstract][Full Text] [Related]
15. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
16. Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
Ottichilo RK; Polyak CS; Guyah B; Singa B; Nyataya J; Yuhas K; John-Stewart G; Waitumbi JN
J Infect Dis; 2017 Jan; 215(1):88-94. PubMed ID: 28077587
[TBL] [Abstract][Full Text] [Related]
17. Effect of HIV-1 Serostatus on the Prevalence of Asymptomatic Plasmodium falciparum Parasitemia Among Children Less Than 5 Years of Age in Benin City, Nigeria.
Okonkwo IR; Ibadin MO; Omoigberale AI; Sadoh WE
J Pediatric Infect Dis Soc; 2016 Mar; 5(1):21-8. PubMed ID: 26908488
[TBL] [Abstract][Full Text] [Related]
18. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
[TBL] [Abstract][Full Text] [Related]
19. Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting.
Kakuru A; Natureeba P; Muhindo MK; Clark TD; Havlir DV; Cohan D; Dorsey G; Kamya MR; Ruel T
Malar J; 2016 Oct; 15(1):500. PubMed ID: 27756308
[TBL] [Abstract][Full Text] [Related]
20. HIV infection and the incidence of malaria among HIV-exposed children from Tanzania.
Ezeamama AE; Spiegelman D; Hertzmark E; Bosch RJ; Manji KP; Duggan C; Kupka R; Lo MW; Okuma JO; Kisenge R; Aboud S; Fawzi WW
J Infect Dis; 2012 May; 205(10):1486-94. PubMed ID: 22457274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
